These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 36051887)
1. Network metrics, structural dynamics and density functional theory calculations identified a novel Ursodeoxycholic Acid derivative against therapeutic target Parkin for Parkinson's disease. Naha A; Banerjee S; Debroy R; Basu S; Ashok G; Priyamvada P; Kumar H; Preethi AR; Singh H; Anbarasu A; Ramaiah S Comput Struct Biotechnol J; 2022; 20():4271-4287. PubMed ID: 36051887 [TBL] [Abstract][Full Text] [Related]
2. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches. Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study. Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817 [TBL] [Abstract][Full Text] [Related]
4. Computational Simulations Identified Two Candidate Inhibitors of Cdk5/p25 to Abrogate Tau-associated Neurological Disorders. Zeb A; Son M; Yoon S; Kim JH; Park SJ; Lee KW Comput Struct Biotechnol J; 2019; 17():579-590. PubMed ID: 31073393 [TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Compounds Targeting DJ-1 as Neuroprotectants for Parkinson's Disease by Virtual Screening and In Silico Method. Sharan S; Kumar P; Ambasta RK Curr Comput Aided Drug Des; 2021; 17(3):351-359. PubMed ID: 32303174 [TBL] [Abstract][Full Text] [Related]
6. Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach. Akash S; Hossain A; Hossain MS; Rahman MM; Ahmed MZ; Ali N; Valis M; Kuca K; Sharma R Front Cell Infect Microbiol; 2023; 13():1157627. PubMed ID: 37033493 [TBL] [Abstract][Full Text] [Related]
7. Molecular chaperones and Parkinson's disease. Hu S; Tan J; Qin L; Lv L; Yan W; Zhang H; Tang B; Wang C Neurobiol Dis; 2021 Dec; 160():105527. PubMed ID: 34626793 [TBL] [Abstract][Full Text] [Related]
8. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin. Im E; Yoo L; Hyun M; Shin WH; Chung KC Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820 [TBL] [Abstract][Full Text] [Related]
9. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease]. Hattori N Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506 [TBL] [Abstract][Full Text] [Related]
10. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy. Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187 [TBL] [Abstract][Full Text] [Related]
11. Interaction between Parkin and Madsen DA; Schmidt SI; Blaabjerg M; Meyer M Cells; 2021 Jan; 10(2):. PubMed ID: 33572534 [TBL] [Abstract][Full Text] [Related]
12. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models. Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857 [TBL] [Abstract][Full Text] [Related]
13. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics. Kumar R; Jade D; Gupta D J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945 [TBL] [Abstract][Full Text] [Related]
14. Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease. Zhang K; Zhu S; Li J; Jiang T; Feng L; Pei J; Wang G; Ouyang L; Liu B Acta Pharm Sin B; 2021 Oct; 11(10):3015-3034. PubMed ID: 34729301 [TBL] [Abstract][Full Text] [Related]